Quinn JE - Search Results

1

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

Carser JE, Quinn JE, Michie CO, O'Brien EJ, McCluggage WG, Maxwell P, Lamers E, Lioe TF, Williams AR, Kennedy RD, Gourley C, Harkin DP. Carser JE, et al. Among authors: quinn je. Gynecol Oncol. 2011 Dec;123(3):492-8. doi: 10.1016/j.ygyno.2011.08.017. Epub 2011 Sep 13. Gynecol Oncol. 2011. PMID: 21920589

2

BRCA1: mechanisms of inactivation and implications for management of patients.

Kennedy RD, Quinn JE, Johnston PG, Harkin DP. Kennedy RD, et al. Among authors: quinn je. Lancet. 2002 Sep 28;360(9338):1007-14. doi: 10.1016/S0140-6736(02)11087-7. Lancet. 2002. PMID: 12383682 Review.

3

The role of BRCA1 in the cellular response to chemotherapy.

Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. Kennedy RD, et al. Among authors: quinn je. J Natl Cancer Inst. 2004 Nov 17;96(22):1659-68. doi: 10.1093/jnci/djh312. J Natl Cancer Inst. 2004. PMID: 15547178 Review.

4

BRCA1, a potential predictive biomarker in the treatment of breast cancer.

James CR, Quinn JE, Mullan PB, Johnston PG, Harkin DP. James CR, et al. Among authors: quinn je. Oncologist. 2007 Feb;12(2):142-50. doi: 10.1634/theoncologist.12-2-142. Oncologist. 2007. PMID: 17296808 Free article. Review.

5

BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy.

Quinn JE, James CR, Stewart GE, Mulligan JM, White P, Chang GK, Mullan PB, Johnston PG, Wilson RH, Harkin DP. Quinn JE, et al. Clin Cancer Res. 2007 Dec 15;13(24):7413-20. doi: 10.1158/1078-0432.CCR-07-1083. Clin Cancer Res. 2007. PMID: 18094425

6

BRCA1 and implications for response to chemotherapy in ovarian cancer.

Quinn JE, Carser JE, James CR, Kennedy RD, Harkin DP. Quinn JE, et al. Gynecol Oncol. 2009 Apr;113(1):134-42. doi: 10.1016/j.ygyno.2008.12.015. Epub 2009 Jan 24. Gynecol Oncol. 2009. PMID: 19168207 Review.

7

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.

Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG, Harkin DP. Quinn JE, et al. Cancer Res. 2003 Oct 1;63(19):6221-8. Cancer Res. 2003. PMID: 14559807

8

BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3.

Gilmore PM, McCabe N, Quinn JE, Kennedy RD, Gorski JJ, Andrews HN, McWilliams S, Carty M, Mullan PB, Duprex WP, Liu ET, Johnston PG, Harkin DP. Gilmore PM, et al. Among authors: quinn je. Cancer Res. 2004 Jun 15;64(12):4148-54. doi: 10.1158/0008-5472.CAN-03-4080. Cancer Res. 2004. PMID: 15205325

9

Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.

Kwak EL, Moberg KH, Wahrer DC, Quinn JE, Gilmore PM, Graham CA, Hariharan IK, Harkin DP, Haber DA, Bell DW. Kwak EL, et al. Among authors: quinn je. Gynecol Oncol. 2005 Jul;98(1):124-8. doi: 10.1016/j.ygyno.2005.04.007. Gynecol Oncol. 2005. PMID: 15913747

10

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.

Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PB, Reid G, Johnston PG, Watson PH, Harkin DP. Kennedy RD, et al. Among authors: quinn je. Cancer Res. 2005 Nov 15;65(22):10265-72. doi: 10.1158/0008-5472.CAN-05-1841. Cancer Res. 2005. PMID: 16288014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters